Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings

Authors:
  • MFM Fay
    M Fay
  • BCB Cohen
    B Cohen
  • RCR Campeas
    R Campeas
  • JGJ M Gorman
    J M Gorman
  • MLM R Liebowitz
    M R Liebowitz

Abstract
Six of eight patients with obsessive-compulsive disorder had an exacerbation of symptoms when given m-chlorophenylpiperazine. Fenfluramine and placebo produced mild improvement. Six patients given intravenous clonidine experienced marked reduction in obsessions. Implications for serotonergic and noradrenergic hypotheses of obsessive-compulsive disorder are discussed.

This publication has 8 references indexed in Scilit: